UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052392
Receipt number R000059334
Scientific Title Studies to improve the detection rate of VHD in Japan - cardiology outpatient study -
Date of disclosure of the study information 2023/10/03
Last modified on 2025/07/31 17:04:44

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Studies to improve the detection rate of VHD in Japan - cardiology outpatient study -

Acronym

Studies to improve the detection rate of VHD in Japan - cardiology outpatient study -

Scientific Title

Studies to improve the detection rate of VHD in Japan - cardiology outpatient study -

Scientific Title:Acronym

Studies to improve the detection rate of VHD in Japan - cardiology outpatient study -

Region

Japan


Condition

Condition

Cardiovascular disease

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effectiveness of visually represented cardiac murmurs and signs of heart conditions, visualized as images by the phonocardiograph, in screening for valvular heart disease and atrial fibrillation detection in real clinical settings.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

We calculate the accuracy rate of the detected cardiac murmurs and valvular heart disease (VHD) indicators from phonocardiograms* compared with the VHD diagnostic results based on echocardiography.
*AMI-SSS01 Series Phonocardiograph

Key secondary outcomes

We calculate the accuracy rate of the detected atrial fibrillation (AF) indicators from phonocardiograms* compared with the AF diagnostic results based on echocardiography.
*AMI-SSS01 Series Phonocardiograph


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Cardiology outpatients
2) 65 years or older

Key exclusion criteria

1) Patients with artificial heart valve implants
2) Patients with implanted cardiac pacemaker
3) Patients with congenital heart disease

Target sample size

270


Research contact person

Name of lead principal investigator

1st name Kazuomi
Middle name
Last name Kario

Organization

Jichi Medical University School of Medicine

Division name

Division of Cardiovascular Medicine, Department of Medicine

Zip code

329-0498

Address

3311-1, Yakushiji, Shimotsuke, Tochigi

TEL

0285-58-7538

Email

kkario@jichi.ac.jp


Public contact

Name of contact person

1st name Noriko
Middle name
Last name Harada

Organization

Jichi Medical University School of Medicine

Division name

Division of Cardiovascular Medicine, Department of Medicine

Zip code

329-0498

Address

3311-1, Yakushiji, Shimotsuke, Tochigi

TEL

0285-44-2130

Homepage URL


Email

harada.noriko@jichi.ac.jp


Sponsor or person

Institute

Jichi Medical University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Edwards Lifesciences Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Hyogo Medical University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Jichi Medical University Hospital Bioethics Committee for Clinical Research

Address

3311-1, Yakushiji, Shimotsuke, Tochigi

Tel

0285-58-8933

Email

rinri@jichi.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

自治医科大学附属病院


Other administrative information

Date of disclosure of the study information

2023 Year 10 Month 03 Day


Related information

URL releasing protocol

N/A

Publication of results

Partially published


Result

URL related to results and publications

N/A

Number of participants that the trial has enrolled

270

Results

A total of 266 individuals aged 65 years or older (mean age 74.6 years; 54.5% male) were included in the analysis. The sensitivity of phonocardiography for mild or more severe AS was 92.9%, and the specificity was 98.4%. The sensitivity of auscultation was 85.7%, and the specificity was 94.8% (p-value 0.36).
In the diagnosis of VHD, new phonocardiography provided relatively high sensitivity and specificity, especially for AS.

Results date posted

2025 Year 07 Month 31 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Inclusion criteria:
1. Cardiology outpatients
2. 65 years or older

Exclusion criteria:
1. Patients with artificial heart valve implants
2. Patients with an implanted cardiac pacemaker
3. Patients with congenital heart disease

Participant flow

The subject will undergo an examination using the AMI-SSS01 Series Phonocardiograph, and a cardiac ultrasound examination will be performed on the same day.
Based on the results of the phonocardiogram test, a physician will make a diagnosis, compare it with the results of the echocardiogram test, and calculate the percentage of correct answers for the diagnosis of valvular heart disease.

Adverse events

None

Outcome measures

Primary outcomes:
Calculate the correct response rate of the phonocardiography test by comparing the number of valvular heart disease (VHD) diagnoses based on echocardiography to the number of heart murmurs and signs of VHD detected by the AMI-SSS01 Series Phonocardiograph.

Secondary outcomes:
Calculate the correct response rate of the phonocardiogram test by comparing the number of atrial fibrillation (AF) diagnoses based on echocardiography to the signs of AF detected by the AMI-SSS01 Series Phonocardiograph.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 04 Month 26 Day

Date of IRB

2023 Year 04 Month 26 Day

Anticipated trial start date

2023 Year 06 Month 13 Day

Last follow-up date

2024 Year 03 Month 29 Day

Date of closure to data entry

2025 Year 07 Month 31 Day

Date trial data considered complete


Date analysis concluded

2024 Year 12 Month 31 Day


Other

Other related information

1. The participants undergo both phonocardiograms* and echocardiography on the same day.
2. The results of VHD detection from the phonocardiograms are compared with the outcomes of echocardiography, and the accuracy rate is calculated.
3. The following information is collected from medical records:
1)Patient background (birthdate, date of visit, gender, medical history, underlying conditions, medications, self-reported symptoms)
2)Physical examination findings (height, weight, office blood pressure, auscultation findings)
3)Phonocardiogram findings, echocardiography findings
4. The following results are also collected from medical records if performed:
1)Electrocardiogram
2)CAVI (Cardio-Ankle Vascular Index) test
3)Hematological tests (hemoglobin level, red blood cell count)
4)Biochemical tests (AST, ALT, GGT, creatinine, blood glucose, LDL-C, HDL-C, TG, NT-proBNP)
5)Urinalysis (protein, glucose)

*AMI-SSS01 Series Phonocardiograph.


Management information

Registered date

2023 Year 10 Month 03 Day

Last modified on

2025 Year 07 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059334